
(20R)-Ginsenoside Rh1
CAS No. 80952-71-2
(20R)-Ginsenoside Rh1( —— )
Catalog No. M19132 CAS No. 80952-71-2
20S, 20R ginsenoside-Rh1 can inhibit the thrombin-induced conversion of fibrinogen to fibrin.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 49 | In Stock |
![]() ![]() |
10MG | 87 | In Stock |
![]() ![]() |
25MG | 157 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product Name(20R)-Ginsenoside Rh1
-
NoteResearch use only, not for human use.
-
Brief Description20S, 20R ginsenoside-Rh1 can inhibit the thrombin-induced conversion of fibrinogen to fibrin.
-
Description20S, 20R ginsenoside-Rh1 can inhibit the thrombin-induced conversion of fibrinogen to fibrin.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number80952-71-2
-
Formula Weight638.9
-
Molecular FormulaC36H62O9
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (156.53 mM)
-
SMILESO1[C@H]([C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O)O[C@@H]1[C@H]2C([C@H](CC[C@@]2([C@@H]2[C@@](C1)([C@@]1(CC[C@@H]([C@H]1[C@@H](C2)O)[C@@](C)(CCC=C(C)C)O)C)C)C)O)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yu HS,et al. [Chemical constituents from processed rhizomes of Panax notoginseng]. Zhongguo Zhong Yao Za Zhi. 2013 Nov;38(22):3910-7.
molnova catalog



related products
-
MBP (68-82), guinea ...
Myelin Basic Protein (68-82), guinea pig, is a peptide with the sequence Tyr-Gly-Ser-Leu-Pro-Gln-Lys-Ser-Gln-Arg-Ser-Gln-Asp-Glu-Asn.Myelin Basic Protein (MBP) (68-82), guinea pig is a fragment of myelin basic protein (MBP).
-
tri-GalNAc-COOH
Tri-GalNAc-COOH is a ligand for the asialoglycoprotein receptor (ASGPR) and is commonly used in lysosomal targeting chimera (LYTAC) investigations.
-
Opicinumab
Opicinumab (BIIB033) is a novel monoclonal antibody against LINGO-1 that may be used to prevent and delay acute optic neuritis and recurrent multiple sclerosis.